InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.9403
-0.0797 (-7.81%)
At close: Mar 25, 2026, 4:00 PM EDT
0.9600
+0.0197 (2.10%)
After-hours: Mar 25, 2026, 7:28 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $67.98 million as of March 25, 2026. Its market cap has decreased by -3.03% in one year.
Market Cap
67.98M
Enterprise Value
14.48M
1-Year Change
-3.03%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $67.98M, a decrease of -80.63%. That is a compound annual growth rate of -17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 73.70M | 7.75% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 73.96M |
| PMV Pharmaceuticals | 73.06M |
| Grace Therapeutics | 72.57M |
| MediciNova | 72.36M |
| XBiotech | 71.95M |
| Gain Therapeutics | 70.75M |
| Coeptis Therapeutics Holdings | 69.64M |
| BeyondSpring | 67.35M |